Redox-Triggered Nanomedicine via Lymphatic Delivery: Inhibition of Melanoma Growth by Ferroptosis Enhancement and a Pt(IV)-Prodrug Chemoimmunotherapy Approach (2022)
Attributed to:
Chemical And Nanotechnology-Based Drug Delivery Systems For Cancer Immunotherapy
funded by
EPSRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1002/adtp.202200179
Publication URI: http://dx.doi.org/10.1002/adtp.202200179
Type: Journal Article/Review
Parent Publication: Advanced Therapeutics
Issue: 2